Our Services
Medical Information
Helpful Resources
Published on: 9/28/2026
Short courses of dexamethasone, typically a few days to two weeks, most often cause temporary effects such as insomnia, increased appetite, mood swings, elevated blood sugar, fluid retention, and stomach irritation, which usually fade after the medication stops. Long-term or repeated use carries a different and more serious risk profile, including bone thinning, cataracts and glaucoma, muscle weakness, thinning skin, weight gain with fat redistribution, higher infection risk, and adrenal suppression that requires gradual tapering rather than abrupt stopping. Dose, duration, age, and existing conditions like diabetes, osteoporosis, or hypertension all change how likely these effects are, so two people on the same prescription may experience very different outcomes. There are several important distinctions between brief and prolonged treatment, along with warning signs that warrant prompt medical attention, explained in full below. See below for the complete breakdown before deciding what your symptoms mean for you.
Because dexamethasone can blur the line between an expected side effect and a new problem needing care, it helps to sort your symptoms before your next appointment. A free, instant, online symptom check walks you through targeted questions, highlights possible explanations for what you are feeling, and points you toward the right level of care, whether that is monitoring at home, calling your prescriber, or seeking urgent help. It takes only a few minutes and gives you clearer language to describe your experience to a clinician.
Last reviewed for medical accuracy: 09/28/2026
Dexamethasone is a potent corticosteroid often prescribed to reduce inflammation, suppress the immune system, and manage conditions such as asthma, allergic reactions, certain cancers, and COVID-19 complications. While dexamethasone can be highly effective, its side effects vary significantly depending on whether it’s used for a few days (short course) or weeks to months (long-term use).
Below, we compare the typical dexamethasone side effects seen with short courses versus long-term therapy, explain ways to manage risk, and advise when to seek professional help.
Short courses of dexamethasone are commonly used for:
Most people tolerate dexamethasone for a few days with minimal issues. Possible side effects include:
These effects typically resolve within days of stopping the drug.
When dexamethasone is prescribed for chronic conditions—such as autoimmune disorders, organ transplants, or certain cancers—side effects can become more pronounced and may require ongoing management.
Hormonal and Metabolic Effects
Bone and Muscle Health
Immune System Suppression
Eye and Skin Changes
Mood and Cognitive Effects
Gastrointestinal Issues
| Side Effect Category | Short Course | Long-Term Use |
|---|---|---|
| Mood & Sleep | Mild irritability, insomnia | Significant mood swings, depression, sleep disturbances |
| Metabolic Changes | Transient hunger, slight fluid retention | Weight gain, hypertension, diabetes onset or worsening |
| Immune Function | Minimal impact | Marked suppression, repeated or severe infections |
| Bone & Muscle | Uncommon | Osteoporosis, fractures, muscle wasting |
| Skin & Eyes | Rare | Cataracts, glaucoma, thinning skin, slow healing |
| Gastrointestinal Effects | Occasional heartburn | Ulcers, bleeding, chronic indigestion |
Abruptly stopping dexamethasone after long-term use can cause withdrawal symptoms and adrenal crisis. A typical taper schedule might reduce your dose by 10–20% every week or two, but your doctor will tailor this to your needs.
If you experience any of the following while on dexamethasone, contact your healthcare provider immediately:
If you’re unsure whether your symptoms are serious, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker: https://ubiehealth.com/
Dexamethasone can be lifesaving in many situations, but it demands respect for its potential side effects. Working closely with your healthcare team helps ensure you get the anti-inflammatory or immunosuppressive benefits you need while minimizing harm.
Key takeaways:
Disclaimer: This information is for educational purposes and does not replace medical advice. If you experience life-threatening or serious symptoms, call emergency services or speak to a doctor right away.
(References)
* Burch EA Jr, Goldschmidt TJ, Schwartz BD. Drug intake and the dexamethasone suppression test. J Clin Psychiatry. 1986 Mar;47(3):144-6. PMID: 3949724.
* Rye B, Krusinski PA. Hepatonecrosis resulting from parenteral gold therapy in pemphigus vulgaris. J Am Acad Dermatol. 1993 Jan;28(1):99-101. doi: 10.1016/0190-9622(93)70019-p. PMID: 8425980.
* Asakawa H, Araki T, Yamamoto N, Imai I, Yamane M, Tsutsumi Y, Kawakami F. Allergy to ethylenediamine and steroid. J Investig Allergol Clin Immunol. 2000 Nov-Dec;10(6):372-4. PMID: 11206939.
* Kintzel PE. Prophylaxis for paclitaxel hypersensitivity reactions. Ann Pharmacother. 2001 Sep;35(9):1114-7. doi: 10.1345/aph.10287. PMID: 11573863.
* Melichar B, Cerman J Jr, Malírová E. Successful management of infusion reaction accompanying the start of cetuximab therapy. Support Care Cancer. 2007 Apr;15(4):445-9. doi: 10.1007/s00520-006-0159-x. Epub 2006 Nov 14. PMID: 17103198.
* Hatano K, Nonomura N, Nishimura K, Kawashima A, Mukai M, Nagahara A, Nakai Y, Nakayama M, Takayama H, Tsujimura A, Okuyama A. Retrospective analysis of an oral combination of dexamethasone, uracil plus tegafur and cyclophosphamide for hormone-refractory prostate cancer. Jpn J Clin Oncol. 2011 Feb;41(2):253-9. doi: 10.1093/jjco/hyq178. Epub 2010 Nov 10. PMID: 21071389.
* Brown RS, Farquharson AA, Morton I, Tyler MT. Oral erythema multiforme major: a triple case report. Gen Dent. 2011 Jul-Aug;59(4):302-8. PMID: 21903570.
* Varma SK, Sutradhar S, Misra AK. Levofloxacin and furazolidone induced toxic epidermal necrosis. Indian J Pharmacol. 2013 Nov-Dec;45(6):625-6. doi: 10.4103/0253-7613.121380. PMID: 24347775; PMCID: PMC3847257.
* Watts TJ, Thursfield D, Haque R. Cutaneous adverse drug reaction induced by oral dexamethasone with possible cross-reactivity to Group 1 corticosteroids confirmed by patch testing and intradermal testing. Contact Dermatitis. 2019 Nov;81(5):384-386. doi: 10.1111/cod.13334. Epub 2019 Jul 4. PMID: 31194259.
* Coulombe J, Belzile E, Duhamel A, Rault P, Buteau C, DeBruycker JJ, Bussières JF. Pediatric SJS/TEN Subdued by a Combination of Dexamethasone, Cyclosporine, and Etanercept. J Cutan Med Surg. 2019 Sep/Oct;23(5):547-550. doi: 10.1177/1203475419861078. PMID: 31478770.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.